<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 23-year-old man developed lethal <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> associated with angiographically demonstrable <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral arterial spasm</z:e> while being treated for <z:hpo ids='HP_0011009'>acute</z:hpo> angiotensinogenic <z:hpo ids='HP_0000822'>hypertension</z:hpo> due to a traumatic <z:hpo ids='HP_0001680'>coarctation of the aorta</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This complication occurred even though the treatment maintained his blood pressure at normotensive to mildly hypertensive levels, without producing more than rare and fleeting periods of <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>To explain this enigmatic development, we propose that the high concentration of <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> in the blood constricted the cerebral arteries and thus prevented adequate cerebral autoregulation when his blood pressure was lowered by drug therapy </plain></SENT>
</text></document>